Results 231 to 240 of about 107,682 (255)

Impact of U.S. federal and state generic drug policies on drug use, spending, and patient outcomes: A systematic review

Research in Social and Administrative Pharmacy, 2020
Jingjing Qian
exaly  

A Systematic Review of Physicians’ and Pharmacists’ Perspectives on Generic Drug Use: What are the Global Challenges?

Applied Health Economics and Health Policy, 2015
Helle Hakonsen, Hakonsen Helle, Toverud Else‐Lydia   +2 more
exaly  

Need for Multicriteria Evaluation of Generic Drug Policies

Value in Health, 2015
Diana Brixner, Zoltan Kalo, András Inotai   +2 more
exaly  

Generic drugs.

The Medical letter on drugs and therapeutics, 1986
openaire   +3 more sources

Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration

Annals of Pharmacotherapy, 2009
Barbara Davit, Janet Woodcock, Lawrence X Yu   +2 more
exaly  

Implementation of a Reference-Scaled Average Bioequivalence Approach for Highly Variable Generic Drug Products by the US Food and Drug Administration

AAPS Journal, 2012
Robert Lionberger, Barbara Davit, Lawrence X Yu   +2 more
exaly  

Generic Drug Price Hikes And Out-Of-Pocket Spending For Medicare Beneficiaries

Health Affairs, 2018
Laura E Henkhaus, Geoffrey Joyce, Julie Zissimopoulos   +2 more
exaly  

Generic drug prescriptions following hospital discharge: A prospective study in France

European Journal of Internal Medicine, 2011
Benjamin Wyplosz
exaly  

Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984

Acta Pharmaceutica Sinica B, 2013
exaly  

Intrapatient variation in antiepileptic drug plasma concentration after generic substitution vs stable brand-name drug regimens

Epilepsy Research, 2016
Roberto Riva, Manuela Contin
exaly